VEGFA and small cell lung carcinoma: Soblidotin demonstrated in vivo antivascular effects against tumors overexpressing VEGF in nude BALB/c and CDF1 mice inoculated with SCLC (SBC-3/VEGF) [214] and showed antitumor activity against tumors resistant to docetaxel, paclitaxel, and vincristine [149].